Choose a language
0 reviews
Ignota Labs is a pioneering company dedicated to revitalizing promising yet abandoned drug candidates by addressing safety concerns that have halted their development. Leveraging their proprietary AI platform, SAFEPATH, Ignota Labs integrates deep learning with bioinformatics and cheminformatics to uncover and resolve the underlying mechanisms of drug toxicity. This innovative approach enables the company to rescue drugs that have failed in preclinical or early-phase clinical trials due to safety issues, thereby accelerating the delivery of effective treatments to patients.